82 FR 61003 - Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Evaluation of the Food and Drug Administration's `Fresh Empire' Multicultural Youth Tobacco Prevention Campaign
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration Federal Register Volume 82, Issue 246 (December 26, 2017)
Food and Drug Administration
Federal Register Volume 82, Issue 246 (December 26, 2017)
| Page Range | 61003-61006 | |
| FR Document | 2017-27712 |
[Federal Register Volume 82, Number 246 (Tuesday, December 26, 2017)] [Notices] [Pages 61003-61006] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-27712] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2014-N-2294] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Evaluation of the Food and Drug Administration's `Fresh Empire' Multicultural Youth Tobacco Prevention Campaign AGENCY: Food and Drug Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on an extension of the time period for the outcome evaluation of FDA's multicultural youth tobacco public education campaign, the addition of two rounds of data collection with the original youth surveyed for the outcome evaluation, and recruitment of new youth to participate in those two additional surveys. DATES: Submit either electronic or written comments on the collection of information by February 26, 2018. ADDRESSES: You may submit comments as follows. Please note that late, untimely filed comments will not be considered. Electronic comments must be submitted on or before February 26, 2018. The https://www.regulations.gov electronic filing system will accept comments until midnight Eastern Time at the end of February 26, 2018. Comments received by mail/hand delivery/courier (for written/paper submissions) will be considered timely if they are postmarked or the delivery service acceptance receipt is on or before that date. [[Page 61004]] Electronic Submissions Submit electronic comments in the following way:Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https://www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else's Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov. If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see ``Written/Paper Submissions'' and ``Instructions''). Written/Paper Submissions Submit written/paper submissions as follows: Mail/Hand delivery/Courier (for written/paper submissions): Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. For written/paper comments submitted to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in ``Instructions.'' Instructions: All submissions received must include the Docket No. FDA-2014-N-2294 for ``Evaluation of the Food and Drug Administration's `Fresh Empire' Multicultural Youth Tobacco Prevention Campaign'' Received comments, those filed in a timely manner (see ADDRESSES), will be placed in the docket and, except for those submitted as ``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through Friday. Confidential Submissions--To submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states ``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will review this copy, including the claimed confidential information, in its consideration of comments. The second copy, which will have the claimed confidential information redacted/blacked out, will be available for public viewing and posted on https://www.regulations.gov. Submit both copies to the Dockets Management Staff. If you do not wish your name and contact information to be made publicly available, you can provide this information on the cover sheet and not in the body of your comments and you must identify this information as ``confidential.'' Any information marked as ``confidential'' will not be disclosed except in accordance with 21 CFR 10.20 and other applicable disclosure law. For more information about FDA's posting of comments to public dockets, see 80 FR 56469, September 18, 2015, or access the information at: https://www.thefederalregister.org/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf. Docket: For access to the docket to read background documents or the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the ``Search'' box and follow the prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. FOR FURTHER INFORMATION CONTACT: Amber Sanford, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-8867, [email protected]. SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal Agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. ``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes Agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal Agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, FDA is publishing notice of the proposed collection of information set forth in this document. With respect to the following collection of information, FDA invites comments on these topics: (1) Whether the proposed collection of information is necessary for the proper performance of FDA's functions, including whether the information will have practical utility; (2) the accuracy of FDA's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques, when appropriate, and other forms of information technology. Evaluation of the Food and Drug Administration's `Fresh Empire' Multicultural Youth Tobacco Prevention Campaign (OMB Control Number 0910-0788--Extension) The 2009 Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) (Pub. L. 111-31) amended the Federal Food, Drug, and Cosmetic Act (the FD&C Act) to grant FDA authority to regulate the manufacture, marketing, and distribution of tobacco products to protect public health and to reduce tobacco use by minors. Section 1003(d)(2)(D) of the FD&C Act (21 U.S.C. 393(d)(2)(D)) supports the development and implementation of FDA public education campaigns related to tobacco use. Accordingly, FDA is currently developing and implementing a youth-targeted public education campaign (`Fresh Empire') to help prevent tobacco use among multicultural youth and thereby reduce the public health burden of tobacco. The campaign features events, advertisements on television and radio and in print, digital communications including social media, and other forms of media. Evaluation is an essential organizational practice in public health and a systematic way to account for and improve public health actions. Comprehensive evaluation of FDA's multicultural public education campaign will be used to document whether the intended audience is aware of and understands campaign messages, and whether campaign exposure influences specific cognitive outcomes related to tobacco use that are targeted by the campaign. [[Page 61005]] FDA is in the process of evaluating the effectiveness of its multicultural youth tobacco prevention campaign through an outcome evaluation study that follows the multiple, discrete waves of media advertising planned for the campaign. All information collected is integral to that evaluation. FDA's Fresh Empire youth tobacco public education campaign aims to reduce tobacco use among youth who affiliate with a hip-hop peer crowd, predominantly among African American, Hispanic, and Asian/Pacific Islander youth. The outcome evaluation of the campaign consists of a pre-test survey of youth aged 12 to 17 before campaign launch followed by a series of post-test surveys beginning approximately 6 months after the campaign launch. The post-test surveys are conducted among youth who participated in one or more surveys (the embedded longitudinal cohort) and new participants who are recruited to make up for attrition. Eligible youth were initially 12- to 17-year-old youth who are influenced by the hip-hop peer crowd. Youth in the embedded longitudinal cohort may reach the age of 18 over the course of the evaluation. To date, the pre-test and two post-test surveys have been conducted. A third post-test survey is currently underway. Information has been collected about youth awareness of and exposure to campaign events and advertisements and about tobacco-related knowledge, attitudes, beliefs, intentions, and use. Information has also been collected on demographic variables including age, sex, race/ethnicity, grade level, and primary language. All information is being collected through in-person and web-based questionnaires. Youth respondents were recruited from two sources: (1) A sample drawn from 30 U.S. media markets gathered using an address- based postal mail sampling of U.S. households for the outcome evaluation, and (2) targeted social media (e.g., Facebook). This study is being conducted in support of the provisions of the Tobacco Control Act that require FDA to protect the public health and to educate the population about the risks and potential risks of tobacco use. The information being collected is necessary to inform FDA's efforts towards these goals and to measure the effectiveness and public health impact of the campaign. Data from the outcome evaluation are being used to estimate awareness of and exposure to the campaign among youth in target markets where the campaign is active. Data are also being used to examine statistical associations between exposure to the campaign and subsequent changes in specific outcomes of interest, which include knowledge, attitudes, and beliefs related to tobacco use. FDA requests OMB approval to extend OMB approval of the evaluation of FDA's multicultural youth tobacco public education campaign and to add two additional waves of data collection with existing youth in the study. To accommodate these two additional surveys, FDA requests approval to increase the number of burden hours under the existing control number. The fourth post-test survey will begin in July 2018. The fifth post-test survey will begin in February 2019. As was done in earlier post-test surveys, new youth will be recruited to participate to make up for attrition. A total of 2,100 youth will complete questionnaires for the fourth post-test survey, and the same number will complete questionnaires for the fifth post-test survey. These respondents will include existing youth who have participated in one or more surveys previously (``Longitudinal Cohort'') and new youth recruited via a mail-based screener or social media ads (``Cross-Sectional Refresher Sample''). Based on earlier response rates and longitudinal respondents aging out of the eligibility criteria (over the age of 18), we expect to need to recruit a larger number of cross-sectional respondents than in previous waves. We estimate that approximately 600 longitudinal youth and 1,500 cross-sectional youth will participate in each of the fourth and fifth post-test surveys. With an estimated burden of 45 minutes per respondent, this adds 450 hours for longitudinal respondents and 1,125 hours for cross-sectional respondents for each of the fourth and fifth post-test evaluation surveys. A mail-based screener was one of the methods used to identify eligible youth for the pre-test survey. This method will be used during the fourth post-test survey to recruit new youth to ensure that the sample composition is similar across rounds of data collection. As was done during the pre-test survey, parents or guardians will be asked to provide consent and their contact information on this form. For the fourth post-test survey, the 5-minute youth screener and the 1-minute parental consent will be completed by 9,869 households for a total of 822 burden hours for youth and an additional 164 hours for the parents or guardians. This method will not be used during the fifth post-test survey, for which new participants will be recruited only via social media. We will continue to recruit new youth through social media (e.g., Facebook, Instagram) as a secondary strategy to recruit youth 13 to 17. An online version of the screener described above will continue to be used to identify eligible youth. The screener will take 5 minutes and will be completed by an additional 4,000 youth during each of the fourth and fifth post-test surveys, for a total of 8,000 additional youth respondents and 666 total additional burden hours. The new total number of participants for the youth online post-test screener will be 32,000 and the total burden will be 2,666 hours. This includes the originally-approved 24,000 participants and 2,000 burden hours. As was done previously, eligible youth aged 13 to 14 who complete the online screener will be asked to provide their parents' or guardians' contact information to provide parental consent for the main survey. The process of parents and guardians providing consent for eligible youth will take approximately 1 minute. For the fourth and fifth post-test surveys, we estimate that an additional 700 adults will be contacted to provide consent for eligible youth for a total of 11 additional burden hours. Added to the original 6,000 parents and 100 burden hours, the total number of parental online screener and consents will be 6,700 and the total burden will be 111 hours. With these additions, the estimated number of respondents/responses for all waves of data collection for the study is 107,743, and the total burden is estimated at 15,135 hours--an increase of 4,813 hours from the last approval. FDA estimates the burden of this collection of information as follows: [[Page 61006]] Table 1--Estimated Annual Reporting Burden \1\ -------------------------------------------------------------------------------------------------------------------------------------------------------- Number of Type of respondent Activity Number of responses per Total annual Average burden Total hours respondents respondent responses per response -------------------------------------------------------------------------------------------------------------------------------------------------------- Youth aged 12 to 17 in the United States.. Mail Screener and Consent 13,816 1 13,816 0.0833 1,151 Process--Pre-test outcome survey. Mail Screener and Consent 9,869 1 9,869 0.0833 822 Process--Post-test outcome survey. Adults 18 and older in the United States.. Mail Screener and Consent 13,816 1 13,816 0.0166 229 Process--Pre-test outcome survey. Online Screener and Consent 520 1 520 0.0166 9 Process--Pre-test outcome survey. Mail Screener and Consent 9,869 1 9,869 0.0166 164 Process--Post-test outcome survey. Online Screener and Consent 6,700 1 6,700 0.0166 111 Process--Post-test outcome survey. Multicultural Youth aged 12 to 17 in Pre-test outcome evaluation 2,194 1 2,194 0.5 1,097 select media markets. survey. Longitudinal Cohort, age 13 to 18 years... First post-test evaluation 1,722 1 1,722 0.75 1,292 survey. Second post-test evaluation 1,752 1 1,752 0.75 1,314 survey. Third post-test evaluation 1,365 1 1,365 0.75 1,024 survey. Fourth post-test evaluation 600 1 600 0.75 450 survey. Fifth post-test evaluation 600 1 600 0.75 450 survey. Cross-Sectional Refresher Sample, age 13 First post-test evaluation 682 1 682 0.75 512 to 17 years. survey. 503 1 503 0.75 377 Second post-test evaluation 735 1 735 0.75 551 survey. 1,500 1 1,500 0.75 1,125 Third post-test evaluation 1,500 1 1,500 0.75 1,125 survey. Fourth post-test evaluation survey. Fifth post-test evaluation survey. Multicultural youth aged 13 to 17 in the Pre-test online screener.... 8,000 1 8,000 0.0833 666 select media markets recruiting through Post-test online screener... 32,000 1 32,000 0.0833 2,666 social media and online panels. ------------------------------------------------------------------------------------------------------------- Total................................. ............................ 107,743 .............. .............. .............. 15,135 -------------------------------------------------------------------------------------------------------------------------------------------------------- \1\ There are no capital costs or operating and maintenance costs associated with this collection of information. Dated: December 19, 2017. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2017-27712 Filed 12-22-17; 8:45 am] BILLING CODE 4164-01-P
![Federal Register / Vol. 82, No. 246 / Tuesday, December 26, 2017 / Notices 61003
this collection of information, including Under the PRA (44 U.S.C. 3501– Dated: December 20, 2017.
the necessity and utility of the proposed 3520), federal agencies must obtain William N. Parham, III
information collection for the proper approval from the Office of Management Director, Paperwork Reduction Staff, Office
performance of the agency’s functions, and Budget (OMB) for each collection of of Strategic Operations and Regulatory
the accuracy of the estimated burden, information they conduct or sponsor. Affairs.
ways to enhance the quality, utility, and The term ‘‘collection of information’’ is [FR Doc. 2017–27787 Filed 12–22–17; 8:45 am]
clarity of the information to be defined in 44 U.S.C. 3502(3) and 5 CFR BILLING CODE 4120–01–P
collected, and the use of automated 1320.3(c) and includes agency requests
collection techniques or other forms of or requirements that members of the
information technology to minimize the public submit reports, keep records, or DEPARTMENT OF HEALTH AND
information collection burden. provide information to a third party. HUMAN SERVICES
DATES: Comments must be received by Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a Food and Drug Administration
February 26, 2018.
60-day notice in the Federal Register [Docket No. FDA–2014–N–2294]
ADDRESSES: When commenting, please
concerning each proposed collection of
reference the document identifier or
information, including each proposed Agency Information Collection
OMB control number. To be assured
extension or reinstatement of an existing Activities; Submission for Office of
consideration, comments and
collection of information, before Management and Budget Review;
recommendations must be submitted in
submitting the collection to OMB for Comment Request; Evaluation of the
any one of the following ways:
approval. To comply with this Food and Drug Administration’s ‘Fresh
1. Electronically. You may send your
requirement, CMS is publishing this Empire’ Multicultural Youth Tobacco
comments electronically to http://
notice. Prevention Campaign
www.regulations.gov. Follow the
instructions for ‘‘Comment or Information Collection AGENCY: Food and Drug Administration,
Submission’’ or ‘‘More Search Options’’ 1. Type of Information Collection HHS.
to find the information collection Request: Extension of a currently ACTION: Notice.
document(s) that are accepting approved collection; Title of
comments. SUMMARY: The Food and Drug
Information Collection: Appointment of
2. By regular mail. You may mail Administration (FDA or Agency) is
Representative; Use: The Appointment
written comments to the following announcing an opportunity for public
of Representative form is completed by
address: CMS, Office of Strategic comment on the proposed collection of
beneficiaries, providers and suppliers,
Operations and Regulatory Affairs, certain information by the Agency.
and any party seeking to appoint a
Division of Regulations Development, Under the Paperwork Reduction Act of
representative to assist them with their
Attention: Document Identifier/OMB 1995 (PRA), Federal Agencies are
initial determinations and filing
Control Number lllll , Room C4– required to publish notice in the
appeals. Form Number: CMS–1696
26–05, 7500 Security Boulevard, Federal Register concerning each
(OMB control number: 0938–0950);
Baltimore, Maryland 21244–1850. proposed collection of information,
Frequency: Once; Affected Public:
To obtain copies of a supporting including each proposed extension of an
Individuals and Households, and the
statement and any related forms for the existing collection of information, and
Private sector (Business or other for-
proposed collection(s) summarized in to allow 60 days for public comment in
profits); Number of Respondents:
this notice, you may make your request response to the notice. This notice
3,472,840; Total Annual Responses:
using one of following: solicits comments on an extension of
347,284; Total Annual Hours: 86,821.
1. Access CMS’ website address at the time period for the outcome
(For policy questions regarding this
http://www.cms.hhs.gov/ evaluation of FDA’s multicultural youth
collection contact Katherine Hosna at
PaperworkReductionActof1995. tobacco public education campaign, the
410–786–4993.)
2. Email your request, including your addition of two rounds of data
2. Type of Information Collection
address, phone number, OMB number, collection with the original youth
Request: Extension of a currently
and CMS document identifier, to surveyed for the outcome evaluation,
approved collection; Title of
Paperwork@cms.hhs.gov. and recruitment of new youth to
Information Collection: Medicaid
3. Call the Reports Clearance Office at participate in those two additional
Eligibility and Enrollment (EE)
(410) 786–1326. surveys.
Implementation Advanced Planning
FOR FURTHER INFORMATION CONTACT: Document (IAPD) Template; Use: To DATES: Submit either electronic or
William Parham at (410) 786–4669. assess the appropriateness of states’ written comments on the collection of
SUPPLEMENTARY INFORMATION: requests for enhanced federal financial information by February 26, 2018.
participation for expenditures related to ADDRESSES: You may submit comments
Contents Medicaid eligibility determination as follows. Please note that late,
This notice sets out a summary of the systems, we will review the submitted untimely filed comments will not be
use and burden associated with the information and documentation to make considered. Electronic comments must
following information collections. More an approval determination for the be submitted on or before February 26,
detailed information can be found in advanced planning document. Form 2018. The https://www.regulations.gov
each collection’s supporting statement Number: CMS–10536 (OMB control electronic filing system will accept
and associated materials (see number: 0938–1268); Frequency: Yearly, comments until midnight Eastern Time
ethrower on DSK3G9T082PROD with NOTICES
ADDRESSES). once, and occasionally; Affected Public: at the end of February 26, 2018.
CMS–1696 Appointment of State, Local, or Tribal Governments; Comments received by mail/hand
Representative Number of Respondents: 56; Total delivery/courier (for written/paper
CMS–10536 Medicaid Eligibility and Annual Responses: 168; Total Annual submissions) will be considered timely
Enrollment (EE) Implementation Hours: 2,688. (For policy questions if they are postmarked or the delivery
Advanced Planning Document regarding this collection contact Martin service acceptance receipt is on or
(IAPD) Template Rice at 410–786–2417.) before that date.
VerDate Sep<11>2014 20:21 Dec 22, 2017 Jkt 244001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\26DEN1.SGM 26DEN1](https://thefederalregister.org/doc/82_FR_61249/page/1.svg)
![61006 Federal Register / Vol. 82, No. 246 / Tuesday, December 26, 2017 / Notices
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of re- Average bur-
Number of re- Total annual
Type of respondent Activity sponses per den per re- Total hours
spondents responses
respondent sponse
Youth aged 12 to 17 in the Mail Screener and Consent 13,816 1 13,816 0.0833 1,151
United States. Process—Pre-test out-
come survey.
Mail Screener and Consent 9,869 1 9,869 0.0833 822
Process—Post-test out-
come survey.
Adults 18 and older in the Mail Screener and Consent 13,816 1 13,816 0.0166 229
United States. Process—Pre-test out-
come survey.
Online Screener and Con- 520 1 520 0.0166 9
sent Process—Pre-test
outcome survey.
Mail Screener and Consent 9,869 1 9,869 0.0166 164
Process—Post-test out-
come survey.
Online Screener and Con- 6,700 1 6,700 0.0166 111
sent Process—Post-test
outcome survey.
Multicultural Youth aged 12 Pre-test outcome evaluation 2,194 1 2,194 0.5 1,097
to 17 in select media survey.
markets.
Longitudinal Cohort, age 13 First post-test evaluation 1,722 1 1,722 0.75 1,292
to 18 years. survey.
Second post-test evaluation 1,752 1 1,752 0.75 1,314
survey.
Third post-test evaluation 1,365 1 1,365 0.75 1,024
survey.
Fourth post-test evaluation 600 1 600 0.75 450
survey.
Fifth post-test evaluation 600 1 600 0.75 450
survey.
Cross-Sectional Refresher First post-test evaluation 682 1 682 0.75 512
Sample, age 13 to 17 survey. 503 1 503 0.75 377
years. Second post-test evaluation 735 1 735 0.75 551
survey. 1,500 1 1,500 0.75 1,125
Third post-test evaluation 1,500 1 1,500 0.75 1,125
survey.
Fourth post-test evaluation
survey.
Fifth post-test evaluation
survey.
Multicultural youth aged 13 Pre-test online screener ..... 8,000 1 8,000 0.0833 666
to 17 in the select media Post-test online screener ... 32,000 1 32,000 0.0833 2,666
markets recruiting through
social media and online
panels.
Total ............................. ............................................. 107,743 ........................ ........................ ........................ 15,135
1 There are no capital costs or operating and maintenance costs associated with this collection of information.
Dated: December 19, 2017. DEPARTMENT OF HEALTH AND STRIVERDI RESPIMAT and is
Leslie Kux, HUMAN SERVICES publishing this notice of that
Associate Commissioner for Policy. determination as required by law. FDA
Food and Drug Administration has made the determination because of
[FR Doc. 2017–27712 Filed 12–22–17; 8:45 am]
[Docket No. FDA–2015–E–2582] the submission of an application to the
BILLING CODE 4164–01–P
Director of the U.S. Patent and
Determination of Regulatory Review Trademark Office (USPTO), Department
Period for Purposes of Patent of Commerce, for the extension of a
Extension; STRIVERDI RESPIMAT patent which claims that human drug
ethrower on DSK3G9T082PROD with NOTICES
product.
AGENCY: Food and Drug Administration,
HHS. DATES: Anyone with knowledge that any
ACTION: Notice. of the dates as published (in the
SUPPLEMENTARY INFORMATION section) are
SUMMARY: The Food and Drug incorrect may submit either electronic
Administration (FDA) has determined or written comments and ask for a
the regulatory review period for redetermination by February 26, 2018.
VerDate Sep<11>2014 20:21 Dec 22, 2017 Jkt 244001 PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 E:\FR\FM\26DEN1.SGM 26DEN1](https://thefederalregister.org/doc/82_FR_61249/page/4.svg)
Document Created: 2017-12-23 03:08:19
Document Modified: 2017-12-23 03:08:19
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Dates | Submit either electronic or written comments on the collection of information by February 26, 2018. | |
| Contact | Amber Sanford, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-8867, [email protected] | |
| FR Citation | 82 FR 61003 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR